⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
BGLC News
BioNexus Gene Lab Corp Common stock
Form 8-K
sec.gov
BGLC
BioNexus Gene Lab Corp. Announces Appointment of Dr. Muthu Meyyappan as Chief Commercial Officer of Fidelion Diagnostics to Lead Global Commercialization of the VitaGuard™ MRD Platform
globenewswire.com
BGLC
Belkin Introduces a New Accessory Collection for Samsung Galaxy S26 Series
businesswire.com
BGLC
AMZN
Form 8-K
sec.gov
BGLC
BioNexus Gene Lab Corp. Completes Chemrex Governance Restructuring; Appoints Matthew Barsing as Chairman
globenewswire.com
BGLC
BioNexus Launches Regional Deployment of VitaGuard™ MRD Infrastructure; Positioned to Challenge Legacy Oncology Platforms Across ASEAN’s Multi-Billion Dollar Market
globenewswire.com
BGLC
BGL Real Estate Advisors Structures $135 Million in Real Estate Financing for the Hall of Fame Village
prnewswire.com
BGLC
BioNexus Gene Lab Corp. Completes Strategic Investment in Fidelion Diagnostics; Secures 15% Equity Stake in Global AI-Oncology Platform and Exclusive Southeast Asian Rights for VitaGuard™
globenewswire.com
BGLC
BioNexus Gene Lab Corp. (Nasdaq: BGLC) Secures $500 Million Equity Facility From ARC Group International to Support Expansion of Precision Diagnostics, CDMO Operations, and Therapeutic Commercialization
globenewswire.com
BGLC
BioNexus Gene Lab Corp. (Nasdaq: BGLC) and Fidelion Diagnostics Execute Exclusive Southeast Asia License for VitaGuard™ MRD Platform as Part of Strategic Alliance with Tongshu Gene
globenewswire.com
BGLC